Trial · NCT01635439
Prostin and Propess in Induction of Labor
NCT01635439, Phase 3, Completed, Ain Shams University; results first posted 2012-10-04
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Prostin and Propess in Induction of Labor. Trials, record NCT01635439. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT01635439
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Prostin and Propess in Induction of Labor
- NCT number
- NCT01635439
- Status
- Completed
- Phases
- Phase 3
- Enrollment
- 200 participants, actual
- Lead sponsor
- Ain Shams University
- Conditions
- Labor Pain
- Interventions
- Propess, Prostin E2
- First posted
- 2012-07-09
- Last updated
- 2014-02-06
- Results first posted
- 2012-10-04
Source ClinicalTrials.gov
Registered outcomes5
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Induction to Delivery Interval | 24 hours | |
| Secondary | Induction to Onset of Labor Interval | 24 hours | |
| Secondary | Uterine Hyper-stimulation Rate | 24 hours | |
| Secondary | Need for Syntocinon Augmentation | 24 hours | |
| Secondary | Normal Vaginal Delivery Rate | 24 hours |
Source ClinicalTrials.gov
Outcomes5
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Induction to Delivery Interval | 24 hours | hours | MEAN | |
| SECONDARY | Induction to Onset of Labor Interval | 24 hours | hours | MEAN | |
| SECONDARY | Uterine Hyper-stimulation Rate | 24 hours | participants | NUMBER | |
| SECONDARY | Need for Syntocinon Augmentation | 24 hours | participants | NUMBER | |
| SECONDARY | Normal Vaginal Delivery Rate | 24 hours | participants | NUMBER |
Source ClinicalTrials.gov
Results by group10
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Induction to Delivery Interval | Propess | 22.3 | Standard Deviation 5.7 | hours | |
| Induction to Delivery Interval | Prostin E2 | 21.2 | Standard Deviation 5.3 | hours | |
| Induction to Onset of Labor Interval | Propess | 18.8 | Standard Deviation 5.3 | hours | |
| Induction to Onset of Labor Interval | Prostin E2 | 17.7 | Standard Deviation 5.4 | hours | |
| Uterine Hyper-stimulation Rate | Propess | 1 | participants | ||
| Uterine Hyper-stimulation Rate | Prostin E2 | 1 | participants | ||
| Need for Syntocinon Augmentation | Propess | 5 | participants | ||
| Need for Syntocinon Augmentation | Prostin E2 | 10 | participants | ||
| Normal Vaginal Delivery Rate | Propess | 79 | participants | ||
| Normal Vaginal Delivery Rate | Prostin E2 | 85 | participants |
Source ClinicalTrials.gov
Participant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Propess | 100 | |
| Overall Study | STARTED | Prostin E2 | 100 | |
| Overall Study | COMPLETED | Propess | 100 | |
| Overall Study | COMPLETED | Prostin E2 | 100 | |
| Overall Study | NOT COMPLETED | Propess | 0 | |
| Overall Study | NOT COMPLETED | Prostin E2 | 0 |
Source ClinicalTrials.gov
Adverse events8
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Maternal adverse outcomes | Pregnancy, puerperium and perinatal conditions | Propess | 12 | 100 | 12 |
| other | Maternal adverse outcomes | Pregnancy, puerperium and perinatal conditions | Prostin E2 | 13 | 100 | 13 |
| other | Apgar score < 7 | Pregnancy, puerperium and perinatal conditions | Propess | 0 | 100 | 0 |
| other | Apgar score < 7 | Pregnancy, puerperium and perinatal conditions | Prostin E2 | 1 | 100 | 1 |
| other | Uterine tachysystole | Pregnancy, puerperium and perinatal conditions | Propess | 2 | 100 | 2 |
| other | Uterine tachysystole | Pregnancy, puerperium and perinatal conditions | Prostin E2 | 3 | 100 | 3 |
| serious | Cord pH < 7.1 | Pregnancy, puerperium and perinatal conditions | Propess | 1 | 100 | 1 |
| serious | Cord pH < 7.1 | Pregnancy, puerperium and perinatal conditions | Prostin E2 | 2 | 100 | 2 |
Source ClinicalTrials.gov
Adverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Propess | ||
| Total, all-cause mortality | Prostin E2 | ||
| Total, other adverse events | Propess | 14 | 100 |
| Total, other adverse events | Prostin E2 | 13 | 100 |
| Total, serious adverse events | Propess | 1 | 100 |
| Total, serious adverse events | Prostin E2 | 2 | 100 |
Source ClinicalTrials.gov
Papers1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as |
|---|---|
| 30122579 | DERIVED |
Source PubMed
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons4
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|---|
| Propess vs Prostin E2: Need for Syntocinon Augmentation | Trial comparisons |
| Propess vs Prostin E2: Normal Vaginal Delivery Rate | Trial comparisons |
| Propess vs Prostin E2: Uterine Hyper-stimulation Rate | Trial comparisons |
| Propess vs Prostin E2: serious adverse events | Trial comparisons |
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT01635439
GET https://conductscience.org/api/trials/v1/NCT01635439/registered